About Conjustar
Conjustar is a company based in Shanghai (China) founded in 2022.. Conjustar has raised $27.81 million across 3 funding rounds from investors including Fosun Pharmaceutical, Gree and Shenzhen Qianhai Liyuan. Conjustar operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Shanghai, China
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$27.81 M (USD)
in 3 rounds
-
Latest Funding Round
$12.64 M (USD), Seed
Jan 31, 2024
-
Investors
Fosun Pharmaceutical
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Conjustar
Conjustar has successfully raised a total of $27.81M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $12.64 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Seed — $12.6M
-
First Round
First Round
(21 Feb 2022)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2024 | Amount | Seed - Conjustar | Valuation | Fosun Pharmaceutical | |
| Feb, 2023 | Amount | Angel Round - Conjustar | Valuation | Fosun Health Capital | |
| Feb, 2022 | Amount | Seed - Conjustar | Valuation | Fosun Health Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Conjustar
Conjustar has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Fosun Pharmaceutical, Gree and Shenzhen Qianhai Liyuan. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment fund focused on biopharmaceutical innovation and growth.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Research, development, production, and sale of pharmaceuticals are provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Conjustar
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Conjustar
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Conjustar Comparisons
Competitors of Conjustar
Conjustar operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Conjustar
When was Conjustar founded?
Conjustar was founded in 2022.
Where is Conjustar located?
Conjustar is headquartered in Shanghai, China.
Who is the current CEO of Conjustar?
Shuyi Tang is the current CEO of Conjustar.
Is Conjustar a funded company?
Conjustar is a funded company, having raised a total of $27.81M across 3 funding rounds to date. The company's 1st funding round was a Seed of $7.19M, raised on Feb 21, 2022.
What does Conjustar do?
Conjustar was established in 2022 in Shanghai, China, within the biotechnology sector. Drug conjugates are developed for cancer treatment, with emphasis on miniaturized forms including peptide-drug conjugates, nanobody-drug conjugates, and peptide-drug conjugates. These are designed to target solid tumors. Operations focus on advancing therapeutic options through conjugate technologies, led by CEO Shuyi Tang.
Who are the top competitors of Conjustar?
Conjustar's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Who are Conjustar's investors?
Conjustar has 6 investors. Key investors include Fosun Pharmaceutical, Gree, Shenzhen Qianhai Liyuan, Fosun Health Capital, and Tahoe Ventures.